NASDAQ:APM
Aptorum Group Limited Class A Stock News
$5.50
+0.250 (+4.76%)
At Close: May 01, 2024
5 Investors Betting Big on Aptorum (APM) Group
02:38pm, Wednesday, 06'th Mar 2024
Clinical-stage biopharmaceutical firm Aptorum (NASDAQ: APM ) is seeing its market value rise dramatically today on a merger between its wholly owned subsidiary and an artificial intelligence (AI) and
Why Is Aptorum (APM) Stock Up 346% Today?
11:28am, Wednesday, 06'th Mar 2024
Aptorum (NASDAQ: APM ) stock is rocketing higher on Wednesday after the biopharmaceutical company announced a merger agreement with YOOV Group. This will be a reverse merger that will see YOOV shareho
Why Is Aptorum (APM) Stock Down 16% Today?
08:43am, Monday, 08'th May 2023
Aptorum (NASDAQ: APM ) stock is falling on Monday after the company received a delisting notice from the Nasdaq Stock Market LLC. The reason given for the delisting notice is Aptorum failing to mainta
Aptorum Group shares double after merger plans, earnings delight investors
12:41pm, Wednesday, 03'rd May 2023
Aptorum Group saw its market capitalization double following a busy week where the biopharmaceutical firm released its latest results and announced a merger plan. Shares of the Nasdaq-listed company w
Why Is Aptorum (APM) Stock Up 166% Today?
07:55am, Wednesday, 03'rd May 2023
Aptorum (NASDAQ: APM ) stock is climbing higher on Wednesday despite a lack of news from the clinical-stage biopharmaceutical company. However, trading of APM stock is taking off today with more than
7 Hot Small-Cap Stocks to Buy in September
06:45am, Friday, 02'nd Sep 2022
In general, finding small-cap stocks to buy can be somewhat fraught. These are stocks with market capitalizations between roughly $300 million and $2 billion.
Aptorum Group Limited to Present at the H.C. Wainwright Annual Global Investment Conference, September 13-16, 2022
08:31pm, Thursday, 25'th Aug 2022
NEW YORK & LONDON & PARIS--(BUSINESS WIRE)--Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, au
Aptorum Group Limited to Present at the H.C. Wainwright Global Investment Conference, May 23 – 26 2022
08:13am, Tuesday, 17'th May 2022
NEW YORK & LONDON & PARIS--(BUSINESS WIRE)--Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) a clinical stage biopharmaceutical company dedicated to meeting unmet medical need
Aptorum Group: Advancing Oncology, Autoimmune & Infectious Disease Therapies
08:09pm, Friday, 11'th Feb 2022 Seeking AlphaAptorum Group: Advancing Oncology, Autoimmune & Infectious Disease Therapies
03:09pm, Friday, 11'th Feb 2022
Aptorum Group is advancing therapeutic programs to serve unmet needs in orphan oncology diseases, infectious diseases, metabolic diseases, women's health and other areas.
BATL and PALI among mid-day movers
05:44pm, Thursday, 03'rd Feb 2022 Seeking Alpha
Gainers: BioCardia BCDA +30%.Aptorum Group (APM) +22%.Bon Natural Life BON +17%.Lightning eMotors ZEV +15%.Modine Manufacturing MOD +14%.Battalion Oil (BATL) +13%.DXC
4 Penny Stocks To Buy For Under $5 Outperforming FB Stock In 2022
03:00pm, Thursday, 03'rd Feb 2022
4 penny stocks outperforming Facebook Meta stock today The post 4 Penny Stocks To Buy For Under $5 Outperforming FB Stock In 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | P
Thinking about buying stock in Aptorum Group, Ford Motor, Nokia, Catalyst Biosciences, or General Electric?
03:45pm, Tuesday, 25'th Jan 2022 Benzinga
NEW YORK , Jan. 25, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for APM, F, NOK, CBIO, and GE. … Full story available on Benzinga.com
FMS, GMBL and APM among pre market gainers
01:42pm, Tuesday, 25'th Jan 2022 Seeking Alpha
Aptorum Group (APM) +39%. Sierra Oncology SRRA +36% says late-stage trial for momelotinib in myelofibrosis met key goals.Checkpoint Therapeutics CKPT +18% reports positive results
Aptorum Stock (APM): Why The Price Surged Up Today
10:08am, Tuesday, 25'th Jan 2022
The stock price of Aptorum Group Ltd (NASDAQ: APM) increased by over 34% during intraday trading today. This is why it happened.